Vaccinia infection immune globulin

Treatment — Vaccinia immune globulin must be used in conjunction with a vaccinia vaccine if exposure to a smallpox case occurred more than 4 days earlier. However, only the vaccinia vaccine is required less than 4 days after such contact. The vaccine starts to be protective in approximately 7 days. This vaccine does not provide life-long immunity. Revaccination is recommended at 5- to 10-year intervals. Certain antiviral drugs such as Cidofovir have demonstrated that they confer some protection against infection. Unfortunately, because smallpox has been eradicated, limited research on such drugs has been conducted.3... 

Immune globulin Vaccinia (DynPort Vaccine) Vaccinia infections... 

Vaccinia immune globulin IV is a vaccinia-specific immunoglobulin G (IgG), which directly neutralizes vaccinia virus. It is indicated in treatment and/or modification of aberrant infections induced by vaccinia virus (including accidental implantation in eyes, mouth, or other areas where vaccinia infection would constitute a special hazard), eczema vaccinatum, progressive vaccinia, severe generalized vaccinia, and vaccinia infections in individuals who have skin conditions such as bums, impetigo, varicella-zoster, or poison ivy, or in individuals with eczematous skin lesions. Treat complications that include vaccinia keratitis with caution. 

Vaccinia Vaccinia immune globulin Treatment generalized, ocular, skin infections... 

The CDC estimates that 14 to 52 out of every million people who are vaccinated for smallpox will suffer serious, potentially life-threatening reactions to the vaccine. In these cases, immediate medical attention is required. The first course of treatment is with vaccinia immune globulin (VIG). If a patient does not respond to treatment with VIG, a second option is cidofovir, a drug that currently is approved by the Food and Drug Administration (FDA) to treat specific viral infections of the eye in individuals with compromised immune systems. 

Hobbs and Citron showed that normal serum immunoglobulin levels in a man 38 years old could be associated with a severe antibody deficiency syndrome corrected by y-globulin treatment (H19). Previous workers had shown that deficiencies of antibodies to measles virus (M19), to vaccinia virus (K3), and to other viruses (LIO) in the presence of apparently normal y-globulin, could result in overwhelming infections. However, at those times cellular defects of immunity had not been excluded these now seem a more probable explanation in many cases (H4, Nl). 

---